Compound Detail
CHEMBL1499
CORTISONE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
Basic Information
| ChEMBL ID | CHEMBL1499 |
| Name | CORTISONE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | MFYSYFVPBJMHGN-ZPOLXVRWSA-N |
| Active Moiety | CHEMBL389621 |
6
Targets
9
Activities
4
Assay Types
1
PK Parameters
20
Publications
2
Known Names
3
Indications
Molecular Properties
360.4
MW (Da)
1.99
ALogP
5
HBA
2
HBD
91.7
PSA (Ų)
0.79
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Low Back Pain Osteoarthritis Osteoarthritis, Knee
Activity Summary
EC50 3 meas. best 4.48
IC50 3 meas. best 5.62
Ki 2 meas. best 6.89
Kd 1 meas. best 6.43
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Corticosteroid-binding globulin CHEMBL2421 | Ki | 6.89 | 6.89 | 128.8 | 1 |
| Sex hormone-binding globulin CHEMBL3305 | Kd | 6.43 | 6.43 | 371.5 | 1 |
| Glucocorticoid receptor CHEMBL2034 | Ki | 5.97 | 5.97 | 1081.0 | 1 |
| Glucocorticoid receptor CHEMBL2034 | IC50 | 5.62 | 5.62 | 2378.0 | 1 |
| Multidrug and toxin extrusion protein 1 CHEMBL1743126 | IC50 | 4.67 | 4.67 | 21400.0 | 1 |
| Potassium voltage-gated channel subfamily A member 1 CHEMBL2309 | EC50 | 4.48 | 4.41 | 33000.0 | 2 |
| Unchecked CHEMBL612545 | EC50 | 4.17 | 4.17 | 68000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 17.38 | uL.min-1.(10^6cells)-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 227 |
| - | 10.1101/2024.03.28.586928 | ADMET | 100 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 18806782 | 10.1038/nchembio.114 | Potassium voltage-gated channel subfamily A member 1 | 7 |
| 2897467 | 10.1021/jm00401a015 | Glucocorticoid receptor | 7 |
| 12109909 | 10.1021/jm0102811 | Monoclonal antibody (mAb) | 4 |
| 18806782 | 10.1038/nchembio.114 | Voltage-gated potassium channel subunit beta-1 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL3301361 | ADMET | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 18806782 | 10.1038/nchembio.114 | Unchecked | 2 |
| 18806782 | 10.1038/nchembio.114 | Voltage-gated potassium channel subfamily A member 1/beta-1 | 2 |
| 23241029 | 10.1021/jm301302s | Multidrug and toxin extrusion protein 1 | 2 |
| 2897467 | 10.1021/jm00401a015 | Progesterone receptor | 1 |
| 2897467 | 10.1021/jm00401a015 | Mineralocorticoid receptor | 1 |
| 2897467 | 10.1021/jm00401a015 | Androgen receptor | 1 |
| 8057280 | 10.1021/jm00041a010 | Corticosteroid-binding globulin | 1 |
| 14561088 | 10.1021/jm030861t | Nuclear receptor subfamily 1 group I member 3 | 1 |
Data from ChEMBL 36 via Core Engine